Fidji Simo, OpenAI’s second-in-command, is stepping down from her full-time role overseeing the company’s AGI (Artificial General Intelligence) projects. After an extended medical leave that took longer than she expected, she announced on X that she’ll switch to a part-time advisory position.
Simo first shared in April that she needed a few weeks off to address a neuroimmune condition. This illness affects the nervous system due to immune system issues, leading to symptoms like fatigue and cognitive challenges. Those few weeks stretched into months, and now she won’t be returning to her full-time position at one of the tech industry’s most scrutinized companies.
Who Is Fidji Simo?
Simo joined OpenAI in late 2024 as a high-profile recruit, having previously led the main app at Facebook and served as CEO of Instacart. At OpenAI, she quickly became Sam Altman’s operational partner, responsible for turning AI research into a functioning global business. Losing someone in that role is like a startup founder losing their COO just before a major launch.
Why the Timing Matters
This departure comes at a tricky time for OpenAI. The company is reportedly looking at a potential IPO (Initial Public Offering) and is in a fierce competition with rival AI lab Anthropic for enterprise clients. These situations require steady, experienced leadership.
OpenAI has expanded rapidly, but that growth brings added complexity. Without a clear No. 2, more decisions will fall on CEO Sam Altman, who is already one of the busiest executives in Silicon Valley.
| Detail | Info |
|---|---|
| Founded | 2015 |
| Headquarters | San Francisco, CA |
| CEO | Sam Altman |
| Sector | Artificial Intelligence |
| Simo’s New Role | Part-time advisor |
| Simo’s Previous Role | Head of AGI deployment / No. 2 executive |
What Simo Said
In her post on X, Simo framed her decision around her health rather than any internal issues. She didn’t provide a specific timeline for her advisory role or indicate any disagreement with company leadership. OpenAI hasn’t publicly named anyone to take over her full-time responsibilities.
What This Means
For regular users of ChatGPT and OpenAI’s business tools, this change probably won’t impact the products you use daily. High-level leadership transitions typically unfold over several months. The engineering and product teams that handle updates work largely independently from changes in the C-suite.
The bigger issue is strategic. OpenAI needs to persuade large companies to build their internal tools using its platform instead of a competitor’s. That takes a lot of relationship management, contract negotiations, and long-term planning. A leadership gap at the top can complicate those discussions. If OpenAI loses momentum in the enterprise market, Anthropic, which is actively courting business customers with its Claude AI, could take advantage.
If an IPO does happen, investors will closely examine the stability of the executive team. A revolving door at the No. 2 position can complicate a public offering or delay its timeline.
Community Reactions
“Simo was supposed to be the adult in the room handling the business side while Altman did the vision thing. This is a real gap, not just a PR problem.”
“Wishing her a full recovery. That said, OpenAI really needs to nail down who is actually running operations. It’s been chaotic at the top for a while now.”
What To Watch
- Who fills the role: OpenAI hasn’t announced a replacement yet. Keep an eye out for news about an internal promotion or another high-profile external hire in the coming weeks.
- IPO timeline: Any progress toward a public offering will depend on how quickly OpenAI stabilizes its executive team. Analysts and investors will be watching closely.
- Enterprise competition: Anthropic recently rolled out new features for Claude aimed at business users. If OpenAI’s enterprise efforts stall during this transition, expect Anthropic to seize the opportunity.
- Simo’s advisory role: It’ll be interesting to see whether her part-time involvement remains nominal or becomes more substantial as her health improves.
Sources: TechCrunch | The Verge
Maya Torres
Maya Torres is the Consumer Tech Editor at Explosion.com with 7 years covering product launches for major technology publications. She has reviewed over 300 devices across smartphones, laptops, wearables, and smart home products. Maya specializes in translating spec sheets into real-world buying advice and attends CES, MWC, and Apple keynotes as press. Her reviews focus on helping readers decide what to buy, not just what specs look good on paper.



